title: KLF6-SV1 overexpression accelerates human and mouse prostate cancer progression and metastasis.
abstract: Metastatic prostate cancer (PCa) is one of the leading causes of death from cancer in men. The molecular mechanisms underlying the transition from localized tumor to hormone-refractory metastatic PCa remain largely unknown, and their identification is key for predicting prognosis and targeted therapy. Here we demonstrated that increased expression of a splice variant of the Kruppel-like factor 6 (KLF6) tumor suppressor gene, known as KLF6-SV1, in tumors from men after prostatectomy predicted markedly poorer survival and disease recurrence profiles. Analysis of tumor samples revealed that KLF6-SV1 levels were specifically upregulated in hormone-refractory metastatic PCa. In 2 complementary mouse models of metastatic PCa, KLF6-SV1-overexpressing PCa cells were shown by in vivo and ex vivo bioluminescent imaging to metastasize more rapidly and to disseminate to lymph nodes, bone, and brain more often. Interestingly, while KLF6-SV1 overexpression increased metastasis, it did not affect localized tumor growth. KLF6-SV1 inhibition using RNAi induced spontaneous apoptosis in cultured PCa cell lines and suppressed tumor growth in mice. Together, these findings demonstrate that KLF6-SV1 expression levels in PCa tumors at the time of diagnosis can predict the metastatic behavior of the tumor; thus, KLF-SV1 may represent a novel therapeutic target.
authors.affiliation: Department of Genetics and Genomic Sciences, Mount Sinai School of Medicine, New York, New York 10029, USA.
authors.forename: Goutham
authors.initials: G
authors.lastname: Narla
authors.forename: Analisa
authors.initials: A
authors.lastname: DiFeo
authors.forename: Yolanda
authors.initials: Y
authors.lastname: Fernandez
authors.forename: Saravana
authors.initials: S
authors.lastname: Dhanasekaran
authors.forename: Fei
authors.initials: F
authors.lastname: Huang
authors.forename: Jaya
authors.initials: J
authors.lastname: Sangodkar
authors.forename: Eldad
authors.initials: E
authors.lastname: Hod
authors.forename: Devin
authors.initials: D
authors.lastname: Leake
authors.forename: Scott L
authors.initials: SL
authors.lastname: Friedman
authors.forename: Simon J
authors.initials: SJ
authors.lastname: Hall
authors.forename: Arul M
authors.initials: AM
authors.lastname: Chinnaiyan
authors.forename: William L
authors.initials: WL
authors.lastname: Gerald
authors.forename: Mark A
authors.initials: MA
authors.lastname: Rubin
authors.forename: John A
authors.initials: JA
authors.lastname: Martignetti
mesh_terms: D000818:Animals; D017209:Apoptosis / Q000235:genetics; D045744:Cell Line, Tumor; D004195:Disease Models, Animal; D018450:Disease Progression; D005260:Female; D015972:Gene Expression Regulation, Neoplastic / Q000502:physiology; D006801:Humans; D007150:Immunohistochemistry; D000075723:Kruppel-Like Factor 6; D051741:Kruppel-Like Transcription Factors / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*; D008207:Lymphatic Metastasis; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008819:Mice, Nude; D016513:Mice, SCID; D009362:Neoplasm Metastasis; D009385:Neoplastic Processes; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000378:metabolism* / Q000473:pathology* / Q000601:surgery; D011518:Proto-Oncogene Proteins / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*; D034622:RNA Interference; D013997:Time Factors; D014183:Transplantation, Heterologous
chemical_list: C105465:KLF6 protein, human; D000075723:Kruppel-Like Factor 6; D051741:Kruppel-Like Transcription Factors; D011518:Proto-Oncogene Proteins